Tag: Immunotherapy advancements
Kiromic BioPharma Advances NSCLC T-cell Therapy Deltacel Trial with Dose Expansion
Kiromic BioPharma is making significant progress in the Deltacel-01 clinical trial for the treatment of non-small cell lung cancer (NSCLC). The safety monitoring committee...